Skip to main content

ALERT: Halper Sadeh LLP is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - ADI, GRUB, REXN

NEW YORK, NY / ACCESSWIRE / July 18, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders:

Analog Devices, Inc. (NASDAQ:ADI)

The investigation concerns whether Analog Devices, Inc. and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the merger between Analog Devices and Maxim Integrated Products, Inc. Under the terms of the agreement, Maxim stockholders will receive 0.630 shares of Analog Devices common stock for each share of Maxim common stock they hold at closing. Upon closing, current Analog Devices stockholders will own approximately 69% of the combined company while Maxim stockholders will own approximately 31%. If you are an Analog Devices shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/analog-devices-inc-adi-stock-merger-maxim-integrated-products-mxim.

Grubhub Inc. (NYSE:GRUB)

The investigation concerns whether Grubhub and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Grubhub to Just Eat Takeaway.com N.V. If you are a Grubhub shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/grubhub-inc-grub-stock-just-eat-merger/.

Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN)

The investigation concerns whether Rexahn Pharmaceuticals and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection the merger between Rexahn Pharmaceuticals and Ocuphire Pharma, Inc. If you are a Rexahn Pharmaceuticals shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/rexahn-pharmaceuticals-inc-rexn-stock-merger-ocuphire/.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/597947/ALERT-Halper-Sadeh-LLP-is-Investigating-Whether-the-Following-Mergers-are-Fair-to-Shareholders-Investors-are-Encouraged-to-Contact-the-Firm--ADI-GRUB-REXN

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.